Biolog-id, LLC, a world leader in connected solutions for blood and other high value health products, announced today that LifeShare Blood Center, a leading provider of blood products in the South Central United States, implemented Biolog-id’s RFID-enabled, data analytics solution in its blood supply chain. The deployed solution provides real-time visibility to convalescent plasma from collection to distribution, streamlining inventory, improving efficiency, and ultimately maximizing Return on Donation. Better visibility to the inventory facilitates efficient management of convalescent plasma, and so increases the availability of these scarce and valuable antibodies to the COVID-19 patients who need them.
“Biolog-id LLC has been a strategic partner to our industry, filling a gap in the timely delivery of convalescent plasma,” said Monica Kalvelage, Chief Operations Officer, of LifeShare Blood Center. “Their innovative technology automates a crucial process, enabling a more efficient inventory management and delivery of critical convalescent plasma to COVID-19 patients.”
“The ability to quickly respond to changes in market needs is key to Biolog-id,” said Amit Mayer, VP Innovation & Analytics at Biolog-id LLC. “As a team we were able to move from defining the Covid-19 convalescent plasma solution to implementing it within weeks, all in close cooperation with LifeShare.”
“Convalescent plasma presents LifeShare Blood Center with an incredible opportunity to positively impact the population they serve. Facilitating their move to a digital future on our platform has been a pleasure,” said Troy L. Hilsenroth, CEO Biolog-id LLC. “We are at an exciting time in Biolog-id’s evolution as organizations continue to adopt our solutions to unlock desired operational, clinical, and financial value.
Enabling a new standard of care of how high-value products in healthcare are distributed, stored, utilized, and tracked are central to Biolog-id LLC’s vision.
- Pediatric Inflammatory Multisystem Syndrome different from Kawasaki disease: Study
- Chile: COVID-19 cases top 134K, Quarantine for the communes of San Antonio and Calama
- Equine encephalitis vaccine: Bavarian Nordic announces topline results from the the first-in-human trial
- Outbreak News Update: Robert Herriman talks about the brain eating amoeba, Naegleria fowleri
- Philippines COVID-19 death toll tops 1,000, More than 200 prisoners infected
- Indonesia: Most provinces report less than 10 new COVID-19 cases
- Cytokine storm: Acalabrutinib assists in calming down in COVID-19 patients in study
- False-negative COVID-19 tests: Challenges and implications